first report outbreak ebola virus disease occur yambuku democrat republic congo antibody response survivor year infect document howe report character antiebola persist neutral caps use lisa measure immunology response air erov glycoprotein nucleoprotein ass vp reactive pseudoviru approach plaque reduce test live origin still harbor antibody measure interesting subset serum could neutral postiniti data provide longest document secolo within survivor cohort extend known draw postinfect least symptoms 